Endexx Corp EDXC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EDXC is a good fit for your portfolio.
News
-
Endexx Corporation Reports Substantial Financial Growth and Market Expansion in Annual Financial Results
-
Endexx Corporation's HYLA Accelerates Global Reach in Vape Innovation With Strategic Distribution Milestones
-
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors
-
Endexx Corporation Announces Transition to New Auditor Amid Strategic Evolution
-
Endexx Corporation Announces Strategic Shift in Auditor Services to Bolster Growth and Transparency
Trading Information
- Previous Close Price
- $0.02
- Day Range
- $0.02–0.02
- 52-Week Range
- $0.01–0.05
- Bid/Ask
- $0.02 / $0.02
- Market Cap
- $8.86 Mil
- Volume/Avg
- 304,490 / 263,818
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.37
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Endexx Corp develops CBD-based products. It sells high-end, full-spectrum CBD oils, topicals, and pet products, to support the therapeutic relief of pain and inflammation for humans and pets, through its e-commerce site and other online and in-store retailers. Its product category includes Blesswell, Heritage Line, Topicals, Ingestibles, Maggie's Line, X-Line and Pets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 10
- Website
- https://www.endexx.com
Valuation
|
Metric
|
EDXC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 2.37 |
Price/Cash Flow | — |
Price/Earnings
EDXC
Financial Strength
|
Metric
|
EDXC
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.09 |
Interest Coverage | 5.84 |
Quick Ratio
EDXC
Profitability
|
Metric
|
EDXC
|
|---|---|
Return on Assets (Normalized) | −56.97% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
EDXC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Tdjgltwd | Mjdl | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Rgkcjlpkgx | Pdstt | $70.8 Bil | |
HLN
| Haleon PLC ADR | Trstdqqg | Dtsdg | $37.7 Bil | |
VTRS
| Viatris Inc | Dxnwjvgkm | Glxzz | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Ytkyrqbp | Nfkn | $12.5 Bil | |
CTLT
| Catalent Inc | Pccqhygv | Wqdkgf | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Rtzdrlf | Dqdy | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Vkmyycf | Mnpfl | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jfskqtkc | Xghzqtk | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Vgqvbxvcm | Dydvt | $2.9 Bil |